1.Application of fiberoptic bronchoscopy in the diagnosis and treatment of chronic cough in children
Danqi SHEN ; Han ZHANG ; Yunxiao SHANG
Chinese Pediatric Emergency Medicine 2018;25(1):32-36
Objective To explore the application value of fiberoptic bronchoscopy in the diagnosis and treatment of chronic cough in children. Methods A total of 113 children with chronic cough were enrolled in our hospital from January 2014 to December 2016. All the cases underwent fiberoptic bronchoscopy,the endoscopic manifestations and clinical symptoms were analyzed,and the pathogens in bronchoalveolar lavage fluid were detected. Results In the 113 children with chronic cough,64 cases (56. 6%) were boys and 49 cases (43. 4%) were girls,with 85 cases (75. 2%) under 5 years old. After fiberoptic bronchoscopy,30 cases (26. 5%) were diagnosed with bronchial foreign body,20 cases (17. 7%) were post-infection cough, 19 cases (16. 8%) with cough variant asthma,14 cases (12. 4%) with upper airway cough syndrome,14 cases ( 12. 4%) had airway abnormality, 9 cases ( 7. 9%) had protracted bacterial bronchitis, 4 cases (3. 6%) had bronchiolitis obliterans,and 3 cases (2. 7%) had bronchial tuberculosis. The most common pathogen was Streptococcus pneumonia in bronchoalveolar lavage fluid. The main adverse reactions in the operations was hypoxemia caused by airway obstruction. Conclusion Fiberoptic bronchoscopy is a very safe and reliable operation in the diagnosis and treatment of respiratory diseases in pediatrics, and plays an important role in the diagnosis of congenital developmental airway diseases,the detection of pathogens and the treatment of bronchial foreign bodies. For the chronic cough children who had repeated visits and poor treatment should accept fiberoptic bronchoscopy examination.
2.Tetrahydroisoquinolines as novel histone deacetylase inhibitors for treatment of cancer.
Danqi CHEN ; Aijun SHEN ; Guanghua FANG ; Hongchun LIU ; Minmin ZHANG ; Shuai TANG ; Bing XIONG ; Lanping MA ; Meiyu GENG ; Jingkang SHEN
Acta Pharmaceutica Sinica B 2016;6(1):93-99
Histone acetylation is a critical process in the regulation of chromatin structure and gene expression. Histone deacetylases (HDACs) remove the acetyl group, leading to chromatin condensation and transcriptional repression. HDAC inhibitors are considered a new class of anticancer agents and have been shown to alter gene transcription and exert antitumor effects. This paper describes our work on the structural determination and structure-activity relationship (SAR) optimization of tetrahydroisoquinoline compounds as HDAC inhibitors. These compounds were tested for their ability to inhibit HDAC 1, 3, 6 and for their ability to inhibit the proliferation of a panel of cancer cell lines. Among these, compound 82 showed the greatest inhibitory activity toward HDAC 1, 3, 6 and strongly inhibited growth of the cancer cell lines, with results clearly superior to those of the reference compound, vorinostat (SAHA). Compound 82 increased the acetylation of histones H3, H4 and tubulin in a concentration-dependent manner, suggesting that it is a broad inhibitor of HDACs.